Victoria Vakiener's Net Worth
$569 Thousand
Who is Victoria Vakiener?
Victoria Vakiener does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include CHIMERIX INC, Epizyme, Inc., and ARROWHEAD PHARMACEUTICALS, INC..
SEC CIK
Victoria Vakiener's CIK is 0001826263
Past Insider Trading and Trends
2021 was Victoria Vakiener's most active year for acquiring shares with 4 total transactions. Victoria Vakiener's most active month to acquire stocks was the month of May. 2024 was Victoria Vakiener's most active year for disposing of shares, totalling 3 transactions. Victoria Vakiener's most active month to dispose stocks was the month of December. 2023 saw Victoria Vakiener paying a total of $380,819.67 for 87,447 shares, this is the most they've acquired in one year. In 2024 Victoria Vakiener cashed out on 6,519 shares for a total of $221,748.09, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
CHIMERIX INC (CMRX) Snapshot price: $0.8503
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Epizyme, Inc. No price found
Chief Commercial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.53% | -817.00 |
$11.21 | -$9,158.57 | 52.69K |
Scheduled
|
Feb 4
| ||
Form 4
| +91.20% | 25.52K |
—
|
—
| 53.5K |
Feb 1
| |||
Form 4
| -2.10% | -599.00 |
$11.41 | -$6,834.59 | 27.98K |
Scheduled
|
Jan 25
| ||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) Snapshot price: $22.22
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -5.62% | -1.80K |
$23.31 | -$41,934.69 | 30.2K |
Scheduled
|
May 2
| ||
Form 4
| -12.85% | -4.72K |
$38.10 | -$179,813.40 | 32K |
Scheduled
|
Jan 11
| ||
Form 4
| +68.96% | 14.99K |
$25.41 | $380,819.67 | 36.72K |
Dec 15
| |||
Form 4
| -6.66% | -1.55K |
$26.33 | -$40,811.50 | 21.73K |
Sep 28
| |||
Form 4
| +35.52% | 6.1K |
—
|
—
| 23.28K |
Jan 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||